Peritoneal Dialysis Versus Hemodialysis: Risks, Benefits, and Access Issues

Sinnakirouchenan, Ramapriya; Holley, Jean Lake

doi:10.1053/j.ackd.2011.09.001

Cited by 149 publications

(137 citation statements)

References 35 publications

Supporting

Mentioning

130

Contrasting

Unclassified

Order By: Relevance

“…Prior studies on the association between dialysis type and location have generated mixed results [28,29]. While Sinnakirouchenan and Lukowsky found results similar to our results [30,31], Mehrotara and colleagues found contrary results [32]. Future studies should draw a comparison between the hemodialysis and peritoneal dialysis by the location of the patient.…”

Section: Discussionsupporting

confidence: 55%

Geographic disparities in mortality among the end stage renal disease patients: an analysis of the United States Renal Data System, 2007–08

2016

View full text Add to dashboard Cite

The study was conducted to determine the association between mortality, rurality, and distance from the treatment facility of the patients with ESRD. The United States Renal Data System (USRDS) for the year 2007-08 was utilized to conduct analysis of 181,349 subjects. After adjusting for all other covariates, the odds of mortality were higher among patients in urban and isolated areas (18.1 miles or more from the dialysis facility), compared with those who were living closer (≤3.3 miles, OR 1.08, 95 % CI 1.05-1.12). Conversely, patients living in isolated rural (0-≤3.3 miles, OR 0.95, 95 % CI 0.81-0.96), small adjacent rural (8.1-≤18.1 miles, OR 0.90, 95 % CI 0.77-0.96) and Micropolitan rural quartiles (>18.1 miles, OR 0.96, 95 % CI 0.92-0.97) had lower odds of mortality than their urban counterparts. The Accountable Care Organizations must devise strategies to cater ESRD patients living in remote areas.

show abstract

Section: Discussionsupporting

confidence: 55%

Geographic disparities in mortality among the end stage renal disease patients: an analysis of the United States Renal Data System, 2007–08

2016

View full text Add to dashboard Cite

show abstract

“…16 Despite its cost, HD remains the most utilized modality in North America and Europe as well as countries of Latin America who provide it at lower cost than the United States. 17 Continuous ambulatory PD is the least costly method and if adopted globally by low-and middle-income countries could reduce the cost of renal replacement therapy if PD consumables were made regionally or locally. For example, at present, there is no producer of PD fluid in East Africa, which requires that all fluid be purchased from outside the region.…”

Section: Affordabilitymentioning

confidence: 99%

Developing nephrology programs in very low-resource settings: challenges in sustainability

Yeates

Ghosh

Kilonzo

2013

Kidney International Supplements

View full text Add to dashboard Cite

“…Complications such as infection or peritonitis ultimately highlight hemodialysis as a better option. 43 This statement remains debatable though. Statistically, peritoneal dialysis patients amounts to a mere 8%, with the remaining patients relying on hemodialysis.…”

Section: Peritoneal Dialysismentioning

confidence: 99%

Nanoporous biomaterials for uremic toxin adsorption in artificial kidney systems: A review

Cheah

Ishikawa

Othman

et al. 2016

J. Biomed. Mater. Res.

View full text Add to dashboard Cite

Hemodialysis, one of the earliest artificial kidney systems, removes uremic toxins via diffusion through a semipermeable porous membrane into the dialysate fluid. Miniaturization of the present hemodialysis system into a portable and wearable device to maintain continuous removal of uremic toxins would require that the amount of dialysate used within a closed-system is greatly reduced. Diffused uremic toxins within a closed-system dialysate need to be removed to maintain the optimum concentration gradient for continuous uremic toxin removal by the dialyzer. In this dialysate regenerative system, adsorption of uremic toxins by nanoporous biomaterials is essential. Throughout the years of artificial kidney development, activated carbon has been identified as a potential adsorbent for uremic toxins. Adsorption of uremic toxins necessitates nanoporous biomaterials, especially activated carbon. Nanoporous biomaterials are also utilized in hemoperfusion for uremic toxin removal. Further miniaturization of artificial kidney system and improvements on uremic toxin adsorption capacity would require high performance nanoporous biomaterials which possess not only higher surface area, controlled pore size, but also designed architecture or structure and surface functional groups. This article reviews on various nanoporous biomaterials used in current artificial kidney systems and several emerging nanoporous biomaterials. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 1232-1240, 2017.

show abstract

Peritoneal Dialysis Versus Hemodialysis: Risks, Benefits, and Access Issues

Cited by 149 publications

References 35 publications

Geographic disparities in mortality among the end stage renal disease patients: an analysis of the United States Renal Data System, 2007–08

Geographic disparities in mortality among the end stage renal disease patients: an analysis of the United States Renal Data System, 2007–08

Developing nephrology programs in very low-resource settings: challenges in sustainability

Nanoporous biomaterials for uremic toxin adsorption in artificial kidney systems: A review

Contact Info

Product

Resources

About